The introduction of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable buzz within the medical community. This novel dual GIP and GLP-1 receptor medication seems to deliver impressive improvements in fat shedding compared to current therapies. Early patient data have shown significa